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Managing to Make Markets: 




This paper presents one of the first studies to identify and explain the marketization work of a 
strategic net. Through a study of the Stevenage Bioscience Catalyst – a strategic net formed to 
support the marketization of Life Science Discoveries - we generate insights into the everyday work 
that makes marketization happen. Marketization is understood as the process that enables the 
conceptualisation, production and exchange of goods. Our findings focus on one specific form of 
marketization work found to be core to the strategic net: conceptualisation work.  Three forms of 
conceptualisation work are identified: conceptualising actors’ roles, conceptualising markets and 
conceptualising goods. These manifest as routinized, recursive practices. Our analysis reveals how 
these practices gather together multiple forms of scientific, technical and market knowledge to 
generate new market devices that transform market rules and conventions, and introduce new 
methods and instruments of valuation that change the market. In contrast to extant studies that 
claim a strategic net’s activities influence markets; our findings position the conceptualisation work 
of the strategic net as constitutive of markets and the broader system of provision for ‘healthcare’ 
and ‘health futures’.  
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When technologies advance and innovations emerge, firms collaborate to generate new markets to 
accommodate them (Aarikka-Stenroos & Sandberg, 2012).  In this paper, we ask: what kinds of 
conceptualisation work are performed by a strategic net to bring about changes to markets and their 
broader systems of provision? Strategic nets have been described as intentionally formed networks 
created for a specific strategic purpose (Möller & Rajala, 2007). This literature suggests that 
managers develop strategic nets to collectively re-imagine, co-ordinate and manage change (Adner 
& Kapoor, 2010; Möller & Halinen, 1999; Möller, Rajala, & Svahn, 2005). Möller and Svahn (2006) 
draw on the industrial networks (cf. Håkansson & Waluszewski, 2002), strategic management, 
dynamic capabilities and organisational learning literatures (cf. Zollo & Winter, 2002) to argue that 
strategic nets differ in their governance from other forms of network because they constitute 
deliberate efforts to learn how to create value collectively: the more uncertain the value creation 
system, the more demanding the management of the network.  In other words, uncertainty - and 
hence the demands on managers - increase when technological understanding advances beyond the 
experience of markets (Knight, Pfeiffer, & Scott, 2015).  Thus, managers need to develop capabilities 
that bridge different communities of practice (Lave & Wenger, 1991) - connecting specialist forms of 
technical and professional knowledge - to generate new and more holistic forms of knowing and 
acting (Möller, 2010). In this regard, understanding how markets are collectively conceptualised and 
represented seems central to understanding how strategic nets set agendas and work out how to 
act. Yet the strategic nets literature says relatively little about these practices and processes. To 
understand more we turn to the marketization literature. 
Marketization has been defined as the process that enables the conceptualisation, production and 
exchange of goods (Araujo & Pels, 2015).  In the marketization literature, researchers cite efforts to 
transform market structures, introduce market devices, alter market behaviour, and reconstitute 
market agents as the outcomes of coordinated efforts of actor-networks (Doganova & Karnøe, 2015; 
Kjellberg, Azimont, & Reid, 2015; Onyas & Ryan, 2015). They recognise that to transform and 
innovate markets, actors must work to create new market rules and conventions, and valuation 
methods and practices through the introduction, presentation and circulation of new forms of 
scientific, technical and market knowledge (Çalışkan & Callon, 2010). While, traditionally, the 
marketing literature has focused on enabling exchange between buyers and suppliers, explaining 
how managers align product characteristics with customer demands (Baker & Sinkula, 2002) and 
persuade unknowing potential market actors to value innovative offerings (Jaworski, Kohli, & Sahay, 
2000), exchange is only a part of the marketization process. A focus on exchange neglects the both 
the conceptualisation and production work needed to constitute, innovate and reconfigure market 
systems, and the broader system of provision configures connections between markets (Fine, 2002).  
We argue that there are strong complementarities between the strategic nets literature, which 
makes use of concepts such as capabilities, learning, activities and managing in networks (see, Knight 
et al., 2015; Möller & Rajala, 2007; Möller et al., 2005), and the actor-network-theory informed 
marketization literature which explicates the unfolding practices and materialities that constitute 
markets (see, Araujo, 2007; Kjellberg et al., 2015). Yet these two bodies of literature are relatively 
silent on the work done to conceptualise and represent markets and their broader systems of 
provision (see Möller, 2010; Pollock & Campagnolo, 2015 on agenda setting and matrix building 
respectively as a notable exception).  By bringing these literatures into dialogue, we are better 
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equipped to explore how managers collaborate across organisational boundaries, work strategically 
and manage to conceptualise and make markets. As Möller (2010: 369) observes, “more empirical 
insights are required of the practices that companies are using in agenda construction and 
communication. This is an urgent issue…”. Indeed, we know little of the material artefacts that are 
implicated in this work or how this work becomes transformative for the way markets are 
performed.  
In this paper, we represent findings from an eighteen month study of marketization work of a 
strategic net - the Stevenage Bioscience Catalyst (SBC) - in a Life Sciences context, where the focus 
is on conceptualising and producing goods from living organisms for medical interventions for 
improved healthcare outcomes (cf. Magner, 2002). In such contexts, there is clear potential for 
deliberate, purposive and strategic interventions for market transformation (cf. Harrison, Holmen, 
& Pedersen, 2010). In this paper, we understand work to be the strategic and deliberate practices 
performed by market actors to shape markets (Cochoy & Dubuisson-Quellier, 2013); and practices 
to be the “routinized way in which bodies are moved, objects are handled, subjects are treated, 
things are described and the world is understood" (Reckwitz, 2002: 250). Drawing on both the 
marketization and strategic nets literature, we conceptualise and explain the work SBC does to 
reimagine and make markets. We refer to this particular form of marketization work as 
conceptualisation work. Adopting a performative view, we study how SBC disrupt and problematize 
extant market practices through the conceptualisation work that they do.  In so doing, we identify 
the disruptive conceptualisation practices that transform market practices and devices.   
2. LITERATURE REVIEW 
2.1 Strategic Networks & Strategic Nets 
Strategizing in networks and the formation of strategic networks has been widely discussed in the 
marketing and management literature. Networks set up with a specific strategic intent have been 
referred to as networks of innovation (Chesbrough, 2006; Freytag & Young, 2014; Leydesdorff & 
Meyer, 2006), business ecosystems (Rong, Wu, Shi, & Guo, 2015), value nets (Parolini, 1999) and 
strategic nets (Möller & Rajala, 2007). Möller and Rajala (2007) describe the phenomena of 
emerging strategic nets as a value system in-the-making, that calculates what is of value and to 
whom. In the biotech context, the value of science is not always apparent and, if it is, may not be 
realisable because of technical kick-backs, molecular technology misfires or other risks in the 
innovation process (cf. Callon, 1991; Fernald, Pennings, & Claassen, 2015; Rong et al., 2015). While 
not investigating the process of marketization specifically, this body of work provides in-depth 
insights into the role and the management of strategic networks for the commercialization of 
science.  
An important theme in the strategic networks literature is the relationship between strategic 
networks and the commercialization of science. In this literature commercialisation is understood as 
the exploitation of scientific invention with the objective of reaping financial regards (Perkmann et 
al., 2013).  For Chiesa and Frattini (2011) many of the challenges in commercialization  emerge from 
the novelty of innovations which complicate the adoption of new solutions and raise adoption 
barriers. For other scholars it is the capacity of firms to develop and manage innovation without 
strategic networks that presents a problem (Aarikka-Stenroos & Sandberg, 2012; Story, Hart, & 
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O'Malley, 2009). In a recent review paper, Aarikka-Stenroos et al. (2014) develop a framework 
capturing the role of networks in the process of commercialization,  showing how the indirect and 
unintentional contributions of actors support the creation of markets for innovations.  
Some scholars arguing for  the deliberate and strategic development of such networks have referred 
to them as ecosystems, describing them as “a group of companies – and other entities including 
individuals…. - that interacts and shares a set of dependencies as it produces the goods, technologies 
and services customers need”, (Zahra and Nambisan 2012: 220), and “an independent economic 
community with different stakeholders, including direct industrial players, government agencies, 
industry associations, competitors and customers, who mutually benefit each other and face similar 
outcomes”, (Rong et al 2015: 294).  Rong et al. (2015) describe the efforts of a UK-based 
microprocessor innovator to enter the Chinese market, where high product uncertainty and limited 
network resources presented significant barriers to action. By incubating complementary partners, 
identifying lead partners and integrating other ecosystem partners, the firm developed a working 
ecosystem operating across multiple Chinese markets to constitute a system of provision situated in 
China.  A key point here is the recognition that for science to be commercialised and for innovation 
to be successful, the broader system of provision that is constituted by many and varied inter-
related markets, needs to be taken into account and managed in some way.   
These definitions of strategic networks and ecosystems, have similarities with Moller and Rajala’s 
(2007) conceptualisation of strategic nets. For Möller and Rajala’s (2007) strategic nets are 
understood as an intentionally formed network, created for a specific strategic purpose and 
incorporating a finite number of members. We adopt this definition of strategic nets in this paper. 
This conceptualisation enables us to focus our study on common interests and the valuable technical 
and market knowledge that underlies collaborative moves. As we have seen, strategic nets are 
understood to contribute towards the creation of entirely new business fields and markets (Möller, 
2010; Möller & Svahn, 2009), and provide a focal point of resources, required for commercialization 
(Aarikka-Stenroos & Sandberg, 2012).  Two pertinent issues are consistently foregrounded in 
association with strategic nets: their structure and management. 
The structure of strategic nets has been subject to extensive research attention. Harrison, Holmen 
and Pedsen (2010) describe different forms of strategic net initiatives, including building a strategic 
supply network and developing a market entry strategy. Similarly, Möller et al. (2005: 1277) argue 
that strategic nets are not necessarily confined to ‘horizontal’ or ‘vertical’ relationships; where 
horizontal relationships take the form of competition alliances; resource and capability development 
alliances; market and  channel access/cooperation alliances; ‘‘networking forums’’—company or 
institutionally driven. And vertical relationships take the form of supplier nets, channel and customer 
nets and vertically integrated value systems. Strategic nets may also be multidimensional, taking the 
form of complex business nets that require the knowledge and developmental capabilities of 
multiple actors. Importantly, the value-creating characteristics of these networks require distinct 
managerial capabilities (Möller & Halinen, 1999; Möller & Svahn, 2006). 
 
The managerial work performed in strategic nets, though widely recognised as a pertinent and 
pressing topic, has received surprisingly little empirical attention. Möller’s (2010) theoretical 
exploration of the managerial work done in strategic nets, considers the role of sense-making and 
agenda construction in emerging business networks. In so doing, the focus of this study is on 
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‘management cognition’ (what managers think, how they make sense of position and resources, and 
culture and cognition), rather than what managers routinely do in strategic nets.  However, while 
not making explicit reference to routinized management practices, there is some acknowledgement 
of the patterned activities associated with the sense-making work performed within the strategic 
net. 
 Möller’s (2010) argument is an important one. In the complex globalized settings within which many 
of these emerging networks evolve, there are particular challenges for managers working across 
diverse national backgrounds which increase the cognitively-based risk of misunderstanding and 
conflicts. This argument could easily be extended to complex and complementary biotech, robotics 
and digital health fields – where misunderstandings can cause conflict. Conflict often leads to 
innovation failure (Li, Karakowsky, & Lam, 2002; Möller & Svahn, 2004).  In a move towards 
observing what managers do (rather than what they think and understand), Möller and Rajala (2007) 
explain how emerging strategic nets combine old and new actors, introduce radical changes in value 
activities and are uncertain about both the value of activities, the activities needed, and the actors 
that should be involved. However, they do not explicate what Managers do to develop and circulate 
scientific and technical knowledge within and beyond their strategic net; they do not discuss how 
market knowledge informs the collective action of the strategic net, or its power to transform the 
market. If we are to see how a strategic net develops practices that disrupt and reconfigure markets, 
we need to explicate the work a strategic net does to develop and circulate market and scientific 
knowledge, and to see how this information is used to alter market arrangements.   
2.2 Marketization  
The process of marketization has been explored through different perspectives. In politics, 
marketization refers to the “process of taking goods and services that have previously been provided 
under bureaucratic, political or professional means of resource allocation and transferring them to 
market arrangements” (Crouch, 2009: 880). In Science and Technology Studies (STS) marketization 
has been understood as the specific form of economization1 concerned with the making and shaping 
of markets (Çalışkan & Callon, 2010) and is closely associated with innovation: both of the goods 
themselves and of the institutional arrangements made to enable their exchange (Çalışkan & Callon, 
2009; Callon, 2008; Callon & Muniesa, 2005).  While the definition used in politics is certainly 
relevant in the context of health markets, we adopt Çalışkan and Callon’s (2010) definition to 
explicate the process of transforming health markets through innovation in the Life Sciences.  
Çalışkan and Callon (2010: 3) describe marketization as the “…entirety of efforts aimed at describing, 
analyzing and making intelligible the shape, constitution and dynamics of a market socio-technical 
arrangement”. In this definition, the market is understood as an organising system for the 
conceptualisation, production and exchange of goods, constituted through an arrangement of 
heterogeneous human and non-human actants (cf. Latour, 1986; Latour, 2005). Human actants 
include managers, scientists, sales personnel, for example. Non-human actants include animate 
objects (organisms, molecules), epistemic objects (regulations, market representations), technical 
objects (conference facilities, laboratories, computers). The power of actants to configure and 
                                                          
1
 Economization has been defined as the divergent and controversial analyses, (crossing disciplines such as 
economics, sociology and anthropology) that define, explain and enact economic forms of life (Çalişkan and 
Callon 2010).  
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coordinate the practices of the market emerges from the associations made between them: for 
example all the forms of knowledge, expertise and materials that come together to deliver a 
healthcare market (cf. Zuiderent-Jerak, 2009). These associations are often created by equipping 
market actors with the market devices that help them qualify, calculate and compare the value of 
goods.   Karpik (2000), for example, shows how the Michelin guide was designed to “remov[e] the 
unexpected in the discovery of the unknown”, providing advice that was more credible and 
legitimate, and equipping consumers to make judgements about where to stop and eat on their 
journey (cited by Cochoy & Dubuisson-Quellier, 2013: 5).  
Market devices thus play an important role in market transformation and innovation.  Muniesa, 
Millo and Callon (2007: 2) describe market devices as ‘the material and discursive assemblages that 
intervene in the construction of markets’. They cite a variety of examples from analytical techniques 
to pricing models, from purchase settings to merchandising tools, trading protocols and aggregate 
indicators to illustrate the breadth of market devices as objects that are picked up and used in 
practice to shape what markets become, and how they are performed to transform a market. In his 
description of the introduction of the shopping trolley, Cochoy (2009) shows how shoppers, once 
equipped with this new market device, no longer calculate what they should buy using their 
shopping list, but rather by how much they can fit into the trolley. The trolley, as a market device, 
transformed what shoppers are and can do. Similarly, in the shipping industry, the introduction of 
containers as standardised shipping containers transformed how business customers calculated 
(Levinson, 2016; Notteboom & Rodrigue, 2008). 
Market devices can be technical objects (such as the shipping containers) or can be abstract 
conceptualisations of markets or analytical tools. In their paper, ‘Give me a two-by-two matrix and I 
will create the market’, Pollock and D’Adderio (2012) describe how the ‘format and furniture’ of a 
matrix created to describe key players in an IT market, come to mediate and constitute a particular 
market domain. They see the IT market as being a product of the affordances and constraints of 
ranking devices and argue that material things (including market representations) and the economy 
mutually constitute one another. Pollock and D’Adderio (2012) take affordances to be the qualities 
or properties of an object that define its possible uses or make clear how it can or should be used. 
These associations between market devices and the work that actors do to perform markets create 
what Muniesa et al. (2007: 3) describe as ‘an agencement…constituted by fixtures and furnishings, 
by elements that allow tracing lines and constituting territory.’ Yet we know very little of how 
market devices are generated or replaced in practice, and more specifically through the deliberate 
and purposive work of strategic nets. We need to do much more to understand the work done to 
create new market devices and how they are effectively inserted into the world to shape what 
markets become. Understanding this process is likely to generate much greater insights into how 
managers manage to ‘trace lines’ that come to constitute a new market ‘territory’.  
Cochoy and Dubuisson-Quellier (2013: 4) describe the strategic and deliberate work done by market 
actors to produce market devices and shape markets as marketing work. Marketing work shapes 
markets and the judgements made by market actors through the development and circulation of 
market devices. They position marketing work as being part of “… a related market where 
professionals and knowledge compete …. to be acknowledged as a legitimate market 
representation.”  This work can both intervene in markets to transform them, or stabilise markets 
through, for example, setting market rules and conventions, developing methods and instruments of 
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valuation, organising property rights, and developing and circulating scientific, technical and market 
knowledge (Çalışkan & Callon, 2010; Kjellberg et al., 2015). In this sense, markets are the settings in 
which the arrangements for exchange are continually worked out (Loasby, 1999) and are re-
produced through their performance. This unfolding process sees markets as always in the making 
through the ongoing conceptualisation, production and exchange work that market actors do 
(Araujo, 2007).   
This understanding of markets and marketing work departs from the neoclassical view that focuses 
purely on exchange (Buzzell, 1999; Sheth, Gardner, & Garrett, 1988) and instead looks at the 
broader practices that constitute market creation and transformation (Araujo, Kjellberg, & Finch, 
2010; Callon, 1998a; Callon & Muniesa, 2005). However, much of the work on marketization is 
conceptual (Araujo, 2007; Çalışkan & Callon, 2010; Callon & Muniesa, 2005; Kjellberg & Helgesson, 
2006).  Empirical studies are necessarily partial and tend to focus on how particular arrangements 
for exchange are achieved (Finch & Acha, 2008; Kjellberg & Helgesson, 2007), how particular 
innovations in goods transform market arrangements (Harrison & Kjellberg, 2010), or how particular 
arrangements become powerful in configuring customers (Cochoy, 2015). These empirical studies 
have far less to say about the imagining, designing, and making-real of markets as discussed by their 
conceptual counterparts. To do this, we need to study the theoretical and practical, expert and lay 
knowledge, know-how and skills developed and mobilized in the process of designing and managing 
into existence new socio-technical arrangements that become broadly accepted by a community as 
a market.  
2.3 Towards an Analytical Framework to Explore the Marketization Work of Strategic Nets 
Our review of the strategic nets literature suggests that managers work purposively and strategically 
to bring about business field and market change (Jaakkola, Möller, Parvinen, Evanschitzky, & 
Mühlbacher, 2010; Möller, 2010). Yet despite the valuable contribution, we know little about the 
marketization work performed by strategic nets. Looking at the strategic nets literature through a 
marketization lens, taking for example the work of Möller (2010: 369), then 'agenda construction' 
and 'agenda communication' might be additionally understood, not just as sensing making devices 
but as calculative, market device come to perform markets. That come to shape what is 
communicated and how.  While Moller’s (2010) work is largely conceptual, we see the potential here 
to explicate these and other constructs drawn out in the strategic nets and networks literature to 
enable us to identify the powerful relations between them that come to constitute markets. Thus, if 
we understand marketization to be the process that enables the conceptualisation, production and 
exchange of goods (Araujo & Pels, 2015), then, we argue, strategic nets must be engaged in at least 
some elements of this work, with the purpose of transforming markets. To understand the work 
done by strategic nets to engage in the marketization process we would need to know more about 
the practices routinely engaged in to bring about changes in specific elements that perform the 
market – i.e. the market devices used to perform the market (Muniesa et al., 2007; Pollock & 
D’Adderio, 2012).  Specifically we would need to show how market rules and conventions, the 
development of methods and instruments of valuation and the circulation of scientific, technical and 
market knowledge are transformed through the work of the strategic net, and then inserted into the 
worlds of other market actors to transform the way they perform the market (Çalışkan & Callon, 
2010). We might reasonably expect that such market devices connect and cut across markets to 
reshape the broader system of provision (Fine, 2002). Finally, we might usefully work abductively 
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between the networks literature and our data to see what phenomena, constructs and meanings 
might usefully explain our observations so that we are better positioned to explain the unfolding 
marketization process we observe.  
In looking for possible sites of inquiry we engaged with a strategic net that was formed with the 
specific purpose of innovating markets to transform the broader system of provision for healthcare. 
We used this as the focus of our study. So while broadly we set out to understand, what kinds of 
conceptualisation work are performed by a strategic net to bring about changes to markets and their 
broader systems of provision?  More specifically, we ask: 1) What kinds of conceptualisation 
practices does the strategic net perform to generate new and disruptive market devices? and 2) How 
do conceptualisation practices influence particular markets and the broader system of provision?   
Figure 1 summarises our argument into an analytical frame which we use to explore the Stevenage 
Bioscience Catalyst case. The following section introduces and describes the Stevenage Bioscience 
Catalyst as the research context. We then describe the data collection and analysis protocol before 
presenting our findings from this study.   
Figure 1: Analytical Framework: Understanding the work the Strategic Nets do To Transform Markets 
[INSERT FIGURE 1 HERE] 
3.   METHODOLOGY 
Exploring the relationship between the respective practices of strategic nets and the process of 
marketization required a research design that captured the activities, experiences, beliefs and 
intentions of different actors through time, and charted their interactions as they carried out various 
forms of strategic conceptualisation work. Specifically, we paid attention to the routine, recursive 
conceptualisation practices performed by the strategic net. The strategic net is the strategic decision 
making unit that negotiates which practices will be performed by which actors and where. For 
example mentoring meetings between panel experts and mentors; summit meetings that presented 
key ideas on scientific discoveries, markets and the changing health futures landscape, and 
roundtable and networking events where hot topics such as technology convergence, big data and 
its implications for the centre were all discussed that all took place at SBC. We also looked at off-site 
practices such as the Discover Assist programme, where SBC representatives engaged in outreach 
activities, visiting universities and labs to support scientific discoveries and enrol interested scientists 
in SBC’s networking activities. We looked at the patterned practices of SBC representatives 
attending boards and panels of other science incubators and accelerators.   
To identify and access such practices we adopted an abductive, longitudinal, case study approach 
(Langley, 1999; Langley, Smallman, Tsoukas, & Van de Ven, 2013) following the practices of a 
strategic net (Möller & Rajala, 2007). As we began to understand more about the purpose of the 
strategic net, we turned to the marketization literature, which helped us focus our study on what we 
term conceptualisation work (cf. Araujo & Pels, 2015; Cochoy & Dubuisson-Quellier, 2013). We 
understand conceptualisation work as a particular form of marketing work that sets out to reimagine 
markets and their broader systems of provision with the intent to bring about change in them.  As 
we understood more about the conceptualisation work being performed by our strategic net we 
turned back to the literature and adopted theoretical categories of market devices to see how 
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practices were connected with producing and circulating different forms of market devices in order 
to bring about market change (Çalışkan & Callon, 2010). We also returned to the network literature 
to see if phenomena being observed had been described their in any way (cf. Järvensivu & Möller, 
2009). This enabled us to generate the analytical frame presented in Figure 1, and led us to ask more 
specific questions about the types of practices producing market devices and associated market 
interventions.  Finally, we worked iteratively with the data and the literature to identify and label the 
patterned practices we observed (Gioia, Corley, & Hamilton, 2013).  
Abductive, longitudinal research designs such as this are particularly useful to address what, how 
and why questions and the unfolding of practice over time (Alvesson & Skoeldberg, 2009; Easterby-
Smith, Thorpe, & Jackson, 2008; Siggelkow, 2007). Our questions, ‘What kinds of conceptualisation 
practices does the strategic net perform to generate new and disruptive market devices?’ and ‘How 
do conceptualisation practices influence particular markets and the broader system of provision? are 
consequently well disposed to this approach. Qualitative, single-case designs have a long tradition in 
research on networks (Aaboen, Laage-Hellman, Lind, Öberg, & Shih, 2016; Baraldi & Strömsten, 
2009; Guercini & Runfola, 2010), B2B relationships (Finch, Horan & Reid, 2015; Mason & Leek, 2008) 
and strategic nets (Harrison et al., 2010; Partanen & Möller, 2012; Rusko, 2014), more specifically. 
They are valuable when it seems inappropriate to impose prior constructs or theories on the 
informants as a preferred means of explaining of understanding their world (Gioia et al., 2013). For 
example, while we are guided by emergent theories of marketization, there are as yet no empirical 
studies that explain the type of practices routinely performed in doing marketization work. 
Therefore, adopting an inductive approach initially, and then working abductively between the data 
and literature to see how our conceptualisations of the practices performed were recognised in the 
extant literature, seemed likely to generate new and valuable insights (Dubois & Gadde, 2002; 
Järvensivu & Törnroos, 2010). 
Because we wanted to understand more about the deliberate and purposive work strategic nets 
engaged in through their performance of the marketization process, we needed to identify a 
strategic net that had the disruption and re-formation of markets as its purpose. Such initiatives are 
usually strongly associated with innovation and particularly in settings where scientific 
understandings and the development of new technologies are fast-developing, and new methods of 
valuing innovations are needed (Callon, 1998a; Möller & Rajala, 2007; Perkmann et al., 2013). Life 
Sciences fit well into this category (Perkmann et al., 2013). The speed of change and the uncertainty 
of technologies are well-recognised, and the need for new sustainable healthcare provision is widely 
reported in the press, in professional and government reports and is acknowledged as being of 
concern to policy makers (see for example, Life Sciences Industry and UK analysis, 2014). This 
presents the Life Science and biotech markets as suitable contexts to study the marketization 
processes and practices, particularly through the examination of the strategic co-ordinated action of 
a strategic net operating in this sector.  
3.1. Research Context 
In this section we briefly outline the Life Science context to provide a high level picture of the 
strategic net we investigate. This creates the empirical backdrop for the detailed empirical analysis 
of the marketization of Life Science innovation. This paper is based on the case of the Stevenage 
Bioscience Catalyst’s (SBC) strategic net. SBC is a joint venture between GlaxoSmithKline (GSK -a 
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global pharmaceutical firm) and the Wellcome Trust2 , with significant funding from the UK 
Government. SBC is situated on the GSK R&D site, and offers laboratory space and a flexible range of 
scientific and business services as part of their incubation offering  to science entrepreneurs based 
there as tenants. 
Since its inception in 2011, SBC has developed into a major hub for bioscience incubation in the UK. 
It forms a network of organizations that include major pharmaceutical firms, small biotechnology 
companies, research-intensive universities, consultants, venture capitalists and other funding 
organisations, as well as policy-makers. The very purpose of SBC is the marketization of 
biotechnology research, making it an optimal context within which to study the role of strategic nets 
in the process of marketization. To draw boundaries around our case study we adopt Möller et al.’s 
(2005: 1275) definition of a strategic net: “intentionally formed networks that contain a finite set of 
parties, at least three”. In our case we consider SBC, GlaxoSmithKline (GSK), and the SBC tenants 
(which are mostly small biotech start-ups) as a strategic net. We also recognise that SBC was 
constituted by the strategic relationships between the UK Government’s Department for Business, 
Innovation and Skills (BIS), GSK, the Wellcome Trust (WT) and Innovate UK3 and that these 
organisations shape the activities of SBC’s strategic net with GSK and SBC tenants more specifically 
(see section 4.1). 
3.2 Data Collection 
The unit of analysis of our paper is not the network itself, but the practices of SBC’s strategic net. We 
set out to identify practices developed with the purpose of market transformation. We categorised 
the practices we observed as conceptualisation practices (Araujo & Pels, 2015). We found little 
evidence that production and exchange practices were core activities of the strategic net (see Figure 
1). To demonstrate market transformation we needed to identify, 1) the new market devices (i.e. 
rules and conventions, methods and instruments of valuation, scientific, technical and market 
knowledge), being constructed through the practices of the strategic net, and 2) how these new 
market devices were inserted into broader market practices to re-construct market architectures, 
thus transforming how the market was performed (Araujo, 2007). In order to identify 
conceptualisation practices, the transformative market devices they produce, and the new markets 
such devices perform, we collected semi-structured interview, documentary and video data over a 
period of eighteen months. 
Semi-structured Interviews: Our interviewees spanned a range of key stakeholders, including the 
CEO, CFO, Business Manager, and Business Development Manager at SBC as well as the CEOs of nine 
biotechnology firms located at SBC as tenants. We asked interviewees to describe the routine work 
they engaged in to marketize (or ‘bring to market’ SBC#4) the science associated with the SBC 
strategic net. Overall, we conducted thirty-seven interviews (Table 1). Interviews lasted between 
forty-eight minutes and two hours. Interviews were semi-structured (Denzin & Lincoln, 2008). We 
asked interviewees to give us examples of their involvement at SBC as well as their interaction with 
                                                          
2




 Innovate UK is the operating name of the Technology Strategy Board, the UK's innovation agency. It is a UK non-
departmental public body operating at arm's length from the Government reporting to the Department for Business, 
Energy and Industrial Strategy (BIES). 
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other actors within SBC. One practice frequently cited by SBC managers was their support in helping 
tenants to develop their ‘business models’. We followed up on these comments with tenants as they 
described their efforts to marketize their science. We had numerous informal conversations with 
biotech market actors we met at SBC workshops and events which we participated in as note-takers, 
orchestrators and speakers. Participants included tenants from other national and internationally-
based incubators and representatives from pharmaceuticals, biotechs, consultants, lawyers and 
venture capitalists.  
Documentation:  Our analysis draws on documents including business plans, slide-decks, financial 
statements, press releases and the stories reported in the press, grant applications, white papers 
produced by the SBC team and government strategy documentation (cf. Morgan, 1983). Such 
documents provided additional insights into the processes of marketization. They enabled us to 
evaluate the outcome of interactions described in interviews (e.g. the collaboration of biotechnology 
firms for funding bids). 
Video Footage of Events, Panels and Workshops: We were provided with video footage of events, 
workshops and panels organised by SBC. While we did not code the video footage, it provided us 
with background information on debates, problems and unfolding opportunities that were emerging 
from the network over a two-year period. This background information was crucial to understand 
the process of marketization (cf. Langley, 1999).  
Table 1: Summary of data collection and timing 
Timing Interviews* Documents & Videos Events attended 
Month 1  5x Interviews with tenants  Tenants’ Documents that represent 
tenants’ business models 
PR, white papers  
Open Innovation Summit: 
hosted by SBC 200 key 
industry players & start-ups 
in attendance  
3x Interviews with SBC Execs.  SBC documents that represent SBCs 
understanding of SBC’s business model; 
strategy documents and slide decks of 
presentation to board 
 
2x Follow-up video interviews 
with tenants 
Documents that represent SBCs 
understanding of SBC’s business model; 
press release; video footage of open 
innovation summit 
  
Month 4  5x Interviews with tenants  Press releases, newsletters, press cuttings, 
official notes produced from workshop 
Workshop hosted at SBC on ‘The 
Convergence Agenda’ 
3x Interviews with SBC Execs.    
4x Interviews with workshop 
attendees 
  
2x Follow-up video interviews 
with workshop attendees 
  
Month 7  
 
5x Interviews with tenants    
3x Interviews with SBC Execs.  New SBC strategy documents, and pitch 
for 2
nd
 phase of campus expansion 
 
 2x Follow-up video interviews    
Month 
17 
3 x Interviews with SBC Execs Activities audit report commissioned by 
SBC, independent consultant 
Open Innovation Summit: 
hosted by SBC 140 key industry 
players & start-ups in 
attendance. 
Note: Interview* quotes used in this paper are represented as T#1, SBC #1, or GSK #1 for example, to provide some 




3.3 Data Analysis 
Data analysis followed five steps (Gioia et al., 2013). First, we deeply immersed ourselves in the data. 
The video material as well as the interviews with the CEO of SBC provided us with sufficient 
background information on the purpose of the strategic net and its various participants. We 
compiled a descriptive list of activities that linked the various participants. Such activities frequently 
referred to the evaluation of markets and/or identifying/developing business models (used by our 
respondents as a valuation instrument). Detailed descriptions of these activities allowed the team of 
authors to interrogate the data, and formed the foundation for the subsequent analytical steps.   
Second, we compared activity descriptions based on their commonalities and differences. By doing 
this we realized that marketization involved different types of work that we labelled 
‘conceptualisation work’. By discussing themes, we eventually identified three types of 
conceptualisation work: conceptualising actors’ roles, markets and goods. 
Third, following the abductive approach (Dubois & Gadde, 2002; Järvensivu & Törnroos, 2010), we 
moved from our data back to the literature and used Çalışkan and Callon’s (2010) categories of 
market-constituting devices (rules & conventions, methods and instruments of valuation, scientific 
and technical knowledge and market knowledge) to further evaluate the transformative nature of 
the activities mapped out in stage one, for each type of conceptualization work.  
Fourth, we honed in on each type of conceptualisation work (Figure 2) and compared and contrasted 
the descriptive themes for every market constituting device (Tables 2, 3 and 4). Through several 
iterations of data analysis we identified themes that capture the practices that underpin each type 
of conceptualisation  work: conceptualising  actors’ roles (identifying, enrolling, mobilizing), 
conceptualising  markets (mapping, representing, calculating), conceptualising  goods (bundling, 
positioning, valuing).  
Finally, we looked across the different forms of conceptualisation work to see if there was evidence 
across multiple but related goods, markets and actor-networks to generate higher order 
conceptualisations. This enabled us to see  if there were efforts to conceptualise and influence the 
broader system of provision. We found some evidence of this. However, the inherent limitations of 
the research techniques are recognised (Jack, 2005). The study area was restricted, the small 
number of scientitists-entrepreneurs tenants and few broader market actors as participants outside 
of the strategic net, which inhibits generalisation (Larson, 1992). It was also quite a tight time frame 
within which to track the transformation of markets. However, the value of the research lies in its 
capacity to provide insights, rich detial and thick descriptions (Geertz, 1973) to produce a grounded 
model which can generate hypotheses for further testing (Larson, 1992). Further the approach used 
to select respondents provided valuable, rigorous data about the powerful associations we wanted 
to study. 
4. FINDINGS AND ANALYSIS  
The extant market studies literature presents markets as organising systems for the ‘conception, 
production and exchange of goods’ (Araujo & Pels, 2015: 451), positioning them as outcomes of 
markets.  We concur with this view but additionally show how the conceptualisation work of a 
strategic net generates new conceptualisations of markets and goods that contest extant market 
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conventions, valuation methods and the scientific and market knowledge that circulates. Our 
analysis identified three forms of conceptualisation work constituted through distinctive practices: 
conceptualising actors’ roles; conceptualising markets and conceptualising goods (Figure 2). We 
found that as conceptualisation work begins to transform both the constitution of the strategic net 
and the performance of the market, new connections between actors, markets and goods generate 
new conceptualisations of the broader system of provision – which in our case were discussed as 
‘healthcare futures’. We present these findings below. 
Figure 2. Data Structure for the Categorisation of Conceptualisation Work  
 [INSERT FIGURE 2. HERE] 
4.1 Conceptualising Actors’ Roles 
Our analysis foregrounds the conceptualisation work done to develop a strategic net and shape 
collective market action.  We identified three key practices related to conceptualising actors’ roles: 
identifying, enrolling and mobilising. Identifying actors involved working out which actors’ portfolios 
of activities were likely to impact on health market futures, and understanding what these actors 
might bring to the network in terms of knowledge, resources and expertise. Enrolling included 
collectively imagining how actors would become enrolled in any planned action and what specifically 
their role might be. Mobilising work involved imagining and co-ordinating activities that committed 
actors to the fulfilment of those roles (see Table 2).  
We found similarities in the language of the ANT literature and the networks literature in relation to 
the notions of enrolling and mobilising in particular. In ANT inspired studies enrolling and mobilising 
are generally understood to be part of a sociological process of ‘translation’ that engages others in 
the enactment, resituating and co- or re-production of new forms of knowledge and knowing. The 
interest of these scholars is to understand how knowledge is generated through collective networks 
of action (cf. Callon, 1986; Finch & Acha, 2008; Geiger & Finch, 2009). In the networks literature 
enrolling and mobilising are more strongly associated managerial work that lacks the hierarchical 
frame of an organisation and so must be achieved through collaboration in networks of autonomous 
actors (Agranoff & McGuire, 2001; Järvensivu & Möller, 2009). In both cases there is recognition that 
this form of managing is qualitatively different from hierarchical management functions traditionally 
associated with organisations. The emphasis here is on the collaborative, coordinated action. This 
persuades us to see enrolling and mobilising as central to the conceptualising work associated with 
network development and maintenance. 
4.1.1 Identifying and Enrolling Practices 
Identifying and Enrolling practices were often (though not always) performed simultaneously. Early 
conceptualisation work performed by the strategic net was concerned with identifying and enrolling 
actors in the strategic net, in a programme of action: “act[ing] as a catalyst for the 
commercialisation of science” (SBC#1). This included working out the roles of GSK, BIS, WT and 
Innovate UK in creating a Catalyst for the commercialisation of science, and the role of the catalyst 
itself in transforming health markets. The 2009 UK Government’s Commercialization of Life Science 
initiative was behind this effort. The aim was to generate progressive healthcare markets (Bloor, 
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RSriskandarajah, Croxford, & White, 2011), and “…shake up health markets by generating more 
affordable healthcare solutions…as well as generate economic growth” (BIS#3).   
SBC was constituted by the strategic net (Figure 3) with the intent of enacting ‘the commercialisation 
of science’. Each organisation negotiated its role as funders, as providers of resources and expertise, 
and as active members of SBC’s ‘World Class Advisory Board’ (SBC website) in an enrolling process. 
GSK were to provide land for a ‘campus’ development on their site in the South East of England, and 
access to technical services through Scinovo (their discovery and development consulting arm). Both 
GSK and WT were to provide individual scientists with business start-up support.  
As the strategic net worked through this process of enrolling, SBC did significant conceptualisation 
work to generate an identity that explained what SBC would stand for, the types of activities it 
would get involved in and the form it would take. By mapping out the problems faced by those 
attempting to commercialise science (and failing or struggling to do so), the current limitations of 
extant incubation provision of other science parks in the UK, the activities of overseas science parks 
and catalysts, as well as the expertise and resources that might be available within the strategic net, 
the actors in the strategic net began to collectively build an understanding of the structures, 
activities and outcomes that SBC should adopt and develop. This was a recursive process and routine 
analysis and reviews were undertaken, reporting at quarterly board meetings. 
Figure 3. The Key Actors in SBC: Described by SBC as their ‘Model’ 
[INSERT FIGURE 3 HERE] 
 
These concepts were used as valuation instruments to help SBC tenants, and key market actors that 
SBC wanted to enrol (including pharmaceutical companies Johnson & Johnson, Eli Lilly and GE), to 
see the SBC activities ‘not as business as usual’ (SBC#1). SBC used these concepts as tools to mobilise 
the network. By circulating these tools they were equipping the market to calculate and value the 
development and commercialisation of science in a different way. Through these activities SBC 
enacted their role as a ‘catalyst’, developing a,   
“…culture of open innovation [to] accelerate the discovery of cutting-edge healthcare 
solutions and place the UK bioscience sector at the forefront of worldwide biomedical 
innovation” (SBC website, May 2015).  
4.1.2 Mobilising Practices 
One of the outcomes of this early conceptualisation work was the ‘Open Innovation Campus’: 
“…designed to foster cooperation, scientific and commercial dialogue and interaction 
between entrepreneurs in the Incubator and scientists on the GSK R&D site, while 
respecting their freedom to interact with any commercial or academic partners.  ….. and 
to provide access to equipment and facilities that would otherwise be beyond the reach 
of small and medium-sized companies” (SBC#1). 
As the open innovation campus materialises, new market practices are imagined and designed in to 
the workplace (e.g. regular open innovation conferences, seminars and round tables were 
established, a programme named ‘Discover Assist’ was developed to continually identify and enrol 
potential tenants, or actors that could form an important part of existing tenants’ networks).  The 
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campus provides 4,750 square metres of office and laboratory space and valuable opportunities for 
scientific and commercial networking. Tenants retain full independence and the freedom to interact 
with commercial partners and are encouraged to interact and support each other’s activities.   
“We want businesses at the SBC to learn from each other, as well as draw on the 
resources that GSK have to offer.” (SBC#2) 
The role of tenants also became important in the conceptualisation work, with ‘anchor tenants’ 
identified as being ‘of strategic importance’ (SBC#6). Much work was done by SBC to secure the 
tenancy of key market actors thought likely to impact the unfolding science and markets in ‘the 
healthcare space’ (SBC#3). For the SBC team, the selection of tenants was crucial - having science 
ready for progression was a necessary but insufficient qualification for tenancy: 
“They [tenants] have to be right for us. They have to fit. They have to get ‘it’ [pause]... 
the open innovation thing – and some of course are of strategic significance” (SBC#2). 
In this sense, conceptualising actors’ roles extended beyond the work of understanding who was to 
act as part of the strategic net and how, and beyond imagining the actor-networks required to 
develop and launch particular scientific discoveries in particular markets. Ultimately, and 
simultaneous to this work, this form of conceptualisation work spilled over into imagining the 
broader system of provision and became focused on ‘how it could work as a self-sustaining 
ecosystem’ (SBC#2).  
In sum, we found practices conceptualising actors’ roles to be a significant part of the marketization 
process. We saw recursive practices identifying potential market actors, enrolling and mobilising 
those actors and their broader communities as a central part of the work performed by the strategic 
net. We found that the strategic net invoked academic tools and instruments to generate new ways 
of conceptualising market action (e.g. open innovation, ecosystems) and through their circulation, 
contestation and development, made them valuable (Çalışkan & Callon, 2010). Valuation methods 
used in the ‘conceptualising actors roles’ practices of the strategic net - identifying, enrolling and 
mobilising market actors - acted as market devices (Callon, Millo & Muniesa, 2007).  
Our analysis generated further insights into the plastic nature of the strategic net. While the core 
strategic net remained stable, we saw SBC develop and relinquish various powerful associations with 
actors as conceptualisations of what the market was becoming unfolded. This provides a more 
nuanced understanding of how a strategic net is reproduced through its practices. 
16 
 
Table 2: Conceptualising Actor’s Roles to Transform Markets 
Conceptualising 
Actors’ Roles 
Devices that Constitute Markets 
Rules & conventions Methods and instruments of valuation Scientific and technical knowledge Market knowledge 
Identifying 
Who/which key market actors are 
making/breaking the rules and conventions 
of the market  
Who/what is generating new instruments to 
value such advances (in terms of social benefit 
and economic benefit 
Who is generating scientific advances and 
what are the big themes 
Who has market knowledge and how and 
where do they represent those 
understandings of the market. 
“Now we [tenant] know how to go out and 
fundraise, now we know what it’s all about, 
we use the science and the professionalism 
that GSK gives you, but now we can go out 
there and do what we would view as a 
proper job, building biotech.” (T1) 
 
“We’re not using the Twitters and whatever the 
digital methodology… that will change and 
there’s a business opportunity there for doing it 
for drug discovery. … you can then see how 
rather than the government deciding we’re 
going to invest in antibiotics, individuals can 
perhaps have more of an input into how the 
money’s spent.” (T2) 
“… the Discover Assist programme is all about 
finding where the interesting science is 
happening and bringing it into SBC – or 
sometimes even supporting its development 
more remotely” (COO SBC) 
“…identifying the right kind of tenants that 
‘get it’… that understand what we are trying 
to achieve here with an open innovation 
approach is key….  They have to be prepared 
play an active part in this creative, 
supportive culture…” (SBC2) 
Enrolling 
 
Imagining how rules and conventions of 
the market could be changed with 
specified ‘others’ and working to agree 
who will take on the different roles to 
make this happen 
Gaining commitment and ‘buy-in’ from specific 
others to take on the role of developing new 
valuation instruments for new technologies and 
practices 
Engaging others to produce and circulate new 
forms of scientific and technical knowledge as 
part of a ‘community’ 
 
Engaging others to share and generate with 
you ways of describing how the market is 
changing  
 
“We bring together all the regulatory 
agencies so that we can solve these 
problems together” 
(T42) 
“By getting buy-in to the open innovation 
culture we can help tenants build partnership 
and explore relationships that accelerate the 
science and how they bring it to market” (SCB3) 
“we [the tenants] have quite a bit of 
experience now of getting [discovery] funding 
from different grant bodies and we share this 
– so there is quite a bit of community and 
activity around that”  T1) 
“showing folks [start-ups] how they can be 
involved and connecting them with others in 
the market is an important part of what we 
do….” (SBC2) 
Mobilising 
Organising and co-ordinating those that 
will work to change rules and conventions 
of how the market normally works.  
 
Assembling and circulating new and developing 
valuation instruments (e.g. description of 
disease interventions and their value; 
descriptions of new market practices and their 
value; tools and concepts such as the business 
model, open innovation and ecosystem) 
Assembling and circulating new forms of 
scientific and technical knowledge within the 
community 
 
Assembling and circulating new 
understandings of the market and its 
transformation within and beyond the 
community 
 
“Our stakeholders are so complimentary 
about how we built an open innovation 
campus focussing on biotech … And now 
you say, will are gonna expand the business 
model. And all of a sudden you are adding 
on something and you have to convince 
them that this is a natural extension and 
that there are some serious” (MD SBC) 
whatever I see in that area, I will then look at it 
and say, “Does that look like a tangible piece of 
evidence or a valuable piece of research? Is it 
worth me sending it on,” because there’s a 
reputational risk if I’m sending something 
on…(Consultant SBC) 
 
“So at the moment, for bioelectronics, if you 
look in the universities, nobody has a label of 
being a bioelectronics specialist. So they’re 
under the radar and what we’re going to try 
and help is identify, through things like 
Discover Assist, how do we get to those? 
because it’s people who are doing something a 
bit whacky…” (COO SBC) 
 
“so then we went out and essentially went 
out to the Academic Health Science Centres 
and said “look, apply please”. So, we went 
to the leading academic groups and tried to 
explain why this would be an interesting 
thing to do and it wasn’t just about the 
money, we were, as SBC going to try to 
provide support and, you know, a bit of 




4.2 Conceptualising Markets  
We identified three key practices that performed conceptualising markets: mapping, representing 
and calculating. Mapping involved explaining the relations between multiple market actors and their 
activities. Relationships between the wider groups of market actors were not always apparent. 
Understandings of relationships and the potential for co-ordinated, collaborative market action were 
routinely shared between actors within the strategic net.  Representing involved generating 
epistemic objects that illustrated what a market was, in a meaningful way, for a given audience. 
Calculating involved making judgements that promoted certain forms of representation and action 
(see Table 3).  
We observed commonalities between our conceptualisation of mapping and representing markets 
with the way network pictures are described in the networks literature (which has viewed markets as 
networks), as a sense making process (cf. Henneberg, Mouzas & Naude, 2006; Leek & Mason, 2010; 
Mason & Leek, 2012). However, we take this concept further by looking at these as recursive 
practices that produce mappings and representations which have the power to transform how 
markets are performed. In adopting this performative view, we consider the outputs of such 
practices as generative and calculative (Callon & Muniesa, 2005; Mason, Kjellberg, & Hagberg, 2014; 
Pollock & D’Adderio, 2012) in ways that help managers work out what markets might be and how 
they might work in future.  
4.2.1 Mapping Practices 
One of SBC’s key activities was conducting monthly mentoring meetings with tenants. Mentors 
questioned tenants to understand what they were trying to do: mapping out relations between key 
market actors, knowledge or resource gaps and developing avenues for further exploration. This 
mapping process developed the scientific, technical and market knowledge of both the mentor and 
the mentee, and resulted in the identification of new connections that might need to be made within 
and beyond the strategic net as well as generating new representations and calculations. One tenant 
told us: 
“[My mentor] was asking me to explain what I thought the market was for the biomarker 
I’m working on …. he said if you try and sell that to doctors it will be like rolling a stone 
uphill. Why don’t you look at the value of it for pharma? – that changed everything….”  
(T#3) 
Mentoring sessions often resulted in tenants being equipped with new market or scientific 
knowledge and calculative, market devices. These often mobilised tenants into making new 
connections, associations or developing new programmes of action: 
“We’d had several meetings [with different tenants] that had basically made the point 
that explaining the commercial potential of whatever science they [tenant] were doing 
[in grant application forms] was really difficult. So we ran this workshop about 
developing a business model… using the business model canvas to help them [tenants] 
work out their business, and where the value would come….” (SBC#4) 
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The business model canvas4 presents key questions for a business, including a section on ‘customer 
segments’ and asks: ‘for whom are we creating value?’ and ‘who are our most important 
customers?’ and lists ways in which markets are typically represented ‘mass market, niche market, 
segmented, diversified, multi-sided platform’. It urges users to consider key partners, activities and 
relationships and revenue streams.  
These mapping exercises foreground the need for new forms of partnerships. Such mapping 
exercises have shaped the support activities that the strategic net engages in. One of the key themes 
at the 2016 Open Innovation Summit, following business model mapping activities with tenants, was 
The Growing Need for Partnering. At this conference the skills needed to identify and develop good 
partnering relationships, access new knowledge sets and develop and speed up new forms of clinical 
trials for these emergent technologies were explored and ‘best practice’ (SBC  Conference Ad.) 
stories from experienced practitioners were shared.  
Key market actors were invited to these events, both as participants and as speakers; pharma 
companies, venture capitalists, academics, government agencies and so forth.  Networking over 
coffee was encouraged and seen as an important part of these programmes. A number of market 
representations were generated and circulated as a result of these events, including White Papers, 
slide-decks describing size of markets, market growth, new or interesting market actors, descriptions 
of their activities, and the changing practices in the sector. Many of these market representations 
described different health markets, how they overlapped, had potential for expansion and 
speculated about the process and practices that might make imagined futures become real.  
4.2.2 Representing and Calculating Practices 
Representing and calculating practices were sometimes entangled. The business model canvas acted 
as a calculative, market device that helped tenants work out how to represent the potential value of 
their science not only for a specific customer, and for consumers but additionally for the wider 
system of provision for health:  
“… many of these [new] therapies are personalised because they are the patient’s own 
cells. This will change the supply chain - cells go from the patient, to the cell 
manufacture, back to the hospital, and in a time sensitive way. Big pharma don’t want to 
do that –if they don’t they probably won’t be there in 10 years’ time.” (T#42) 
Business models were often re-presented in carefully orchestrated forums, so that they could be 
questioned and their format negotiated; expert panel presentations, in mentoring meetings, in 
tenant support group meetings, at conferences and workshops. One tenant explained, 
“We need to develop orthologous business models… firms that have tried to develop 
solutions and charge high prices are coming up against healthcare economics that 
inevitably squeeze margins. We have put together a reimbursement and financial 
modelling group to work out these new economics” T#42” 
T#42 presents an argument for centring the business model design on the realities of ‘healthcare 
economics’, replacing traditional valuing methodologies in these markets. While in the development 





of disease treatments we consider the logic of social value (i.e. what is socially valuable has 
economic value), few consumers could afford this at full economic cost. The argument here is for 
new forms of calculation based on healthcare economics.   
The business model (and what it calculates) represents a radical change to commercialisation of 
science. Not only are scientists calculating the potential social value of their science (i.e. a cure for 
breast cancer) but additionally they are being equipped to problematize, imagine and explicate the 
system of economic value within which their very particular scientific endeavour sits. The business 
model, the forums within which business models are represented and discussed to explore ‘health 
futures’ generate new representations of imagined re-configured systems of provision for better 
health outcomes that connect the various markets (for cell therapies, for robotics, for digital health) 
together. What is interesting here, is the institutional support structures that are being put in place 
by the strategic net to generate this kind of conceptualisation work. Tenants were being equipped 
(using the concepts of business models; open innovation and ecosystems) to conceptualise and 
connect markets in new ways. These calculations are leading to new conceptualisations of co-
ordinated market action. 
The strategic net generated conceptualisations of markets (often in conversation with tenants), that 
were circulated in wider networks. For example, SBC hosted ‘Convergence Agenda’ workshops and 
annual ‘Open Innovation Summits’ where ‘health futures’ were collectively imagined and the nature 
and pace of change in market practices were discussed, contested and reframed. The ‘Convergence 
Agenda’ workshops focused on uncovering how different technologies were coming together (or 
could potentially be brought together) to generate new health solutions – for example the collision 
of ‘big data’ and its increasingly sophisticated data analytics, with new diagnostics and developing 
science in cell and gene therapies and bioelectronics.   
In sum, we found that conceptualising markets, both for tenants’ individual scientific discoveries, and 
for the broader system of provision, formed a significant part of the strategic net’s work.  This 
evidences claims that indirect and unintentional contributions of actors working to commercialise 
their own science plays a critical role in broader marketization process (cf. Aarikka-Stenroos et al., 
2014). Further, it foregrounds the role of the strategic net in co-ordinating activities and generating 
practices that enables this to happen. We identified recursive practices designed to map out and 
represent the actors that both constitute and connect unfolding markets (e.g. pharmaceutical 
markets, medical devices markets, digital health markets). Such actions made markets calculable in 
new ways. The association between market actors and new scientific and market knowledge was 
generative of such market devices.  Mapping and calculating often took place in carefully designed 
forums where such devices could be readily contested and negotiated. These forums (mentoring 
meetings, conferences, outreach activities etc.) were designed specifically for such purposes.  
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Table 3: Conceptualising Markets  
Conceptualising Markets 
Devices that Constitute Markets 
Rules & conventions Methods and instruments of 
valuation 
Scientific and technical knowledge Market knowledge 
Mapping  
Mapping out relationships between key 
market actors that generate/sustain market 
rules and conventions  
Mapping out groups that are 
working on similar/related valuation 
instruments and methods and their 
(groups of) actors that might use 
such instruments. 
Plotting the relationships between groups that 
are working on similar/related projects  and 
that generate new scientific/technical 
knowledge (i.e. dementia, oncology) potential 
markets (users/consumers) 
Charting and gathering together new 
understandings of the market and their 
dynamics from the broader market system 
“If you left things in the formative stages to 
the market, you may or may not see things 
happen.  We have had to do far more 
environment shaping and stakeholder work 
that I ever would have imagined” (T#42) 
“There is a lot of uncertainty in 
biotech – that’s what puts VCs off. 
So we are working with them to try 
and understand the sort of data 
they need to help them make good 
investment decisions” (SBC#11) 
“if we thought of our biomarker as a way of 
helping big pharma argue for the effectiveness 
of their drug, instead of a way of helping 
doctors work out who should have what drugs, 
then the market becomes much more 
accessible – and how you engage with that 
market is completely different.” (T#3) 
“I’m work with other bioscience incubator 
and accelerator institutions and I’m Chair of 
the UK Bioincubator Forum, representing 24 
bioincubators across the UK – so we talk 
about what’s happening and I’m mapping 
constantly who the key & emerging players 
are so I know what’s going on where.” 
(SBC#2) 
Representing 
Presenting and problematizing 
understandings of market rules and 
conventions  
 
Visualising and presenting new 
forms of valuation for science, 
markets and market practices 
Re-presenting and circulating new 
understandings of science that are 
accessible/meaningful to other non-scientific 
market actors (user groups, VCs etc). 
Characterising different versions of the 
market through different assemblages of 
market knowledge 
 
“… so if you’re going to them [big pharma] you 
need gold plated data, or they’ll want you to 
repeat trials and you lose value” (T#7)  
“James presented a few slides on a 
possible definition of convergence, 
which included three 'bubbles'” 
(COO SBC) 
“if you’re talking to big pharma – they’ll know 
what you’re doing… but VCs are different…. 
they often don’t have a scientific background – 
so being able to nail down and explain what 
you do is crucial” (T#7) 
 
“we present to the board – and it’s not an 
easy ride – they share their thoughts on 
what we think is happening to the market” 
SBC#1 [shows us slide decks including 
market representations by product category  
Calculating 
Assessing which rules and conventions need to 
be changed and how 
 
Assessing if new forms of valuation 
are needed and how these might 
work. 
 
Re-presenting and circulating new 
understandings of science and its potential to 
work out (calculate),  (potential) value 
(social/economic) 
 
Gauging and evaluating what the market is 
becoming, how it is transforming and what 
it might be like in future. 
“We set up a regulatory and clinical trials 
working group to develop a cohesive approach 
to work with regulatory agencies that are 
reaching out and asking for help…  approval 
times have been reduced from 18 months to 
30 days” T#42 
“We need to develop orthologous 
business models… firms that have 
tried to develop solutions and 
charge high prices are coming up 
against healthcare economics that 
inevitably squeeze margins. We 
have put together a reimbursement 
and financial modelling group to 
work out these new economics” 
T#42 
“There would be a little bit of a road show. 
They’d engage with academics. They would 
present some of their germinal ideas in a non-
confidential way and then if they looked to be 
of mutual benefit, which I consider this open 
innovation part, you know, “is there a mutual 
benefit going forward?” then they would be 
invited to engage in a bit more details.” (T#2) 
“convergence … requires new business 
models. And having access to academic 
expertise that can help, and advise and point 
us in directions that opens up maybe new 
business models that we maybe haven’t 






4.3 Conceptualising Goods 
SBC worked with tenants to help them conceptualise specific, tradeable goods. Goods are 
understood to be the bundle of products and/or services that have been made tradable. Goods are 
stable, delimited and definable, with objective properties that allow the application and transfer of 
property rights (Callon & Muniesa, 2005).  We identified three key practices associated with 
conceptualising goods: bundling, positioning and valuing. Bundling involved tenants working out 
whether their science could be sold in a discrete transaction, (as a medical intervention for disease 
X), or as a bundle of ‘science and service’ (T#4), i.e. selling biomarker analytics services to hospitals 
or pharmaceutical companies. Closely associated with this form of conceptualisation work was the 
positioning of imagined goods within specific markets and working out the potential value of the 
trade. Extant research shows that there are very different business models for the commercialisation 
of science; these effect the positioning of goods within specific markets.  Our findings show the work 
the strategic net does to position new and innovative goods within markets or against existing 
offerings, framing new markets. Valuing practices calculate the worth of goods. 
4.3.1 Bundling, Positioning and Valuing Practices 
Our analysis revealed the entangled nature of bundling, positioning and valuing practices as tenants 
and mentors worked to conceptualise goods. Because scientific discoveries ‘live or die’ (T#5) on the 
basis of the data that accompanies them, the strategic net developed practices to support tenants in 
bundling their science with different forms of data to make it into a tradeable good: as ‘phase 1’ or 
‘phase 2’ concepts (T#5). This often took place through a series of mentoring meetings and 
presentations to ‘expert panels’. Experts advised tenants on the types of data that would make the 
science credible.  We saw mentors make particular introductions and connections between tenants 
and other strategic net actors to progress this form of conceptualisation work. Tenant #6, who 
established a research and development start-up in 2011, is a good example: Tenant #6’s science 
focuses on taking molecules from proteins produced by bacteria that have anti-inflammatory 
properties and using them to manipulate the immune system. The company anticipated taking their 
first molecule to Phase One clinical trials within the year. Investors and grants had provided research 
monies to date. Tenant #6 identified the need for “gold-plated data” in order to make their 
molecules valuable – which they needed to “buy-in” (T#6). In this sense, the tradeable good that was 
in need of conceptualising was not the target of the scientific discovery but rather the ‘clinical 
services’ of a credible pharmaceutical company.   
“Gold-plated” or “valuable” data are framed by Tenant #6 as the tradable good for a specific type of 
customer and needed to be purchased in the form of a service from a specific type of potential 
supplier (that might end up being the customer for the molecules under development) -“Big 
Pharma” (T#6).  The data become valuable when they comply with conventional specifications and 
parameters, and when they are present in an accessible and familiar format to potential investors or 
buyers. These are the ‘rules and conventions’ of the market.  Tenant #6 explains: 
“… it’s really important for us to get data associated with our molecules, that is world-
class and super high quality…… so my imagination was, if I’m going to sell this to GSK, 
they need to be happy with the data. …. So I walked across there [points to the GSK 
building out the window]… and it was in the spirit of open innovation, they said they 
could run it in their animal house, they hadn’t run it for anyone outside before. And they 
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had to run it in a certain way that hadn’t been done before. It took eighteen months of 
negotiation…. making sure the scientists were happy to do it, that there was a 
contractual framework – that was quite straight forward…. the really difficult thing and 
the thing that took eighteen months was getting a payment infrastructure in place.” 
GSK had no way of valuing the clinical trials or of managing the income from the clinical trials and so 
could not begin the work until new structures and practices had been put in place.  GSK actors had to 
be equipped to value, so that Tenant #6 could buy their services. Without such services the scientific 
discovery could not be valued.  This is what Çalışkan and Callon’s (2010: 5) refer to as ‘pacifying  
goods’.  In our case we saw that biomedical practices raise difficult problems in terms of economic 
framing (i.e. it was difficult to value scientific discoveries without clinical trial data), so new practices 
had to be developed to deliver this. In this case, some market rules (the data standards) are held, 
while others (buying such data from a ‘big pharma’ company) are transformed. Through this process 
the market architecture is transformed.   
Throughout the marketization process, the goods that need to be conceptualised and made tradable 
are multiple and contrasting in nature within a single system of provision.  As one member of the 
strategic net put it: 
“…most processes coming out of academia were craft-based …they did terrific work but 
those processes are not scalable…. We put a team of people together so processes could 
be made recognisable to a regulatory body and could be controlled, and made 
reproducible. We set up trial groups...put together a project … so that we could encounter 
problems and then lower barriers. Once you’ve lowered the barrier everybody else in the 
sector can play.  Now people are more confident about what needs to be done.  We’ve 
brokered a one-stop-shop for regulators in this space.” (CGTC#42) 
This observation marks a step change from thinking about specific markets for goods to thinking 
about the relationships between markets. The same respondent told us that changes in gene 
therapies would lead to a complete ‘redesign of the supply chain’. 
“treatment involves taking cells out of people’s bodies, editing them and then putting the 
same cells back into the same person’s body in a timely and condition-appropriate 
manner, then hospitals may not be the right places to treat people anymore…. and 
pharma can’t do this….” (CGTC#42) 
The effort to think about health futures was continually challenged and revisited as new discoveries 
in the network emerged.  
For other scientific discoveries bundling and positioning practices required the strategic net to gather 
together market and scientific knowledge to create a powerful argument for why and how a 
particular scientific discovery would engage with the system. A GSK participant explained, 
“…we need to know the platform players. Platform technologies are outside the people 
who pull through the therapies” (GSK#3) 
 
This type of conceptualisation work both positions the discovery within a broader system and looks 
to bundle it with other goods/services to create a ‘solution’ for the market. 
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Table 4: Conceptualising Goods 
Conceptualising 
Goods 
Devices that Constitute Markets 
Rules & conventions Methods and instruments of valuation Scientific and technical knowledge Market knowledge 
Bundling Gathering of information to represent new 
assemblages of ‘goods’ (and scientific 
discoveries) in accordance with market 
conventions by demonstrating ‘market need’ 
Getting together multiple instruments to value 
new forms of goods (i.e. bringing scientific and 
market instruments together to present ‘solutions’ 
to ‘problems’) 
Assembling different forms of scientific 
and technical knowledge to present a 
solution to a problem with scientific-
socio-political dimensions attached (i.e. 
treatment for dementia)  
Assembling ‘market data’ to represent a version of 
healthcare provision and consumption that demonstrates 
demands for new science-service bundles of goods. 
“It was highlighted that we need to 
understand medical/clinical sciences to mean 
*any* science being applied to a medical 
objective, so that we capture the 
bioelectronics side properly - including 
disciplines like engineering, materials science, 
nano, electronics etc. as they get converged 
with neuroscience, physiology etc. in new 
ways.” (SBC Workshop Minutes) 
“Then one of our experts on the expert panel 
worked in neuroscience in Merck and I knew him 
and so he and I sat down together and, basically, 
sifted through this huge list and boiled it down to 
two themes. And we said “right, we’re going to 
pick these two themes and we’re going to put the 
call out for these two themes”. (EIR SBC) 
 
“…we need to know the platform 
players. Platform technologies are 
outside the people who pull through the 
therapies” (GSK#3) 
“Looking at the system  and negotiating new ways of 
accessing services can transform what is brought from 
whom and how.” (T#6) 
Positioning Understanding and articulating and evidencing 
how new goods comply with market 
conventions – to demonstrate 
quality/legitimacy 
Developing practices to demonstrate value by 
developing comparators and valuation instruments 
Marshalling different forms of scientific 
and technical knowledge to position a 
good within a market 
Evidencing how new conceptualisations of goods fit into 
existing markets or act as major market transformers 
(game changers) yet become legitimate/accepted goods in 
a market 
“… if I’m going to sell this to GSK, they need to 
be happy with the data” (T#6)  
“they [tenants] need to know how to explain 
themselves, present their pitch and explain the 
potential value of their science in relation to what 
else is out there.  We share presentation, slides, 
successful grant applications to help them do this.” 
(MD SBC) 
“the value of the network is more about 
the visibility that we have by being 
here; … sometimes they have 
companies like big pharma or large … 
biotech companies come here to take a 
look at the different companies and see 
if there is any possibility of 
collaboration, and through the network 
we have access (T#8) 
“X [mentor] told me if I repositioned how I talk about the 
biomarker, then my market is big pharma and no the NHS 
or other clinicians and that’s much easier to sell into” (T#2) 
Valuing Conventions on data presentation that are 
followed by scientists when presenting their 
ideas to potential investors and grant bodies. 
Goods are evaluated as potential revenue 
generators and existing/new methods of valuation 
(and valuation instruments) are used to present a 
persuasive case for change. 
Scientific evidence is presented to create 
a persuasive case of social value (i.e. 
effective treatment, diagnostics that 
reduce healthcare spend etc.) 
Evidence is marshalled and re-present to value new goods 
in terms of market activity and share.  
 
 “It’s a matter of making sure that we are 
having project plans which is credible to the 
industry …So once we have a data package 
…we’re going to need to present this package 
of data about a drug candidate, if you like, 
investors or pharmaceutical people and it 
needs to be secure” (T#5) 
“… SBC did a workshop using the Business Model 
Canvass. […] There is always a section on grant 
forms where you have to explain the value of your 
science – how you’re going to make money from it 
– and this is the first time you really have to think 
through and be clear about it [….] Several of us 
have used the Business Model Canvas to help us do 
this.” (T#2) 
“we need to get data for proof of 
concept” (T#11) 
“X was really helpful in helping understand how to describe 
the market… and look up figures that gave a sense of the 
market size and the significance of that market – obviously 
the bigger the market the more likely investors are to be 
interested in what you’re doing” (T#7) 
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We found that conceptualising goods for tenants’ individual discoveries often raised questions about 
how the system of provision would support each discovery’s development and marketization. The 
strategic net not only worked to conceptualise goods but through these practices found generated 
new conceptualisations of how the broader system of provision for healthcare would be 
transformed. 
4.4 Conceptualisation Practices and the Broader System of Provision 
While we were able to identify distinct forms of conceptualisation practice, we also observed, 1) that 
the scope and scale of market conceptualisations varied and 2) that connections were frequently 
being made between markets generating broader conceptualisations of healthcare provision.  When 
questioned about this observation, one respondent told us that this was a ‘comfortable shift’ 
(SBC#4) that helped the strategic net work out their own strategy (i.e. where to focus their 
marketization efforts), as well as seeing it as generating valuable market devices for others engaging 
in the market who ‘continuously had their feelers out, mapping out the landscape and charting the 
new terrains’ (SBC#4). We observed that the conceptualising practices generated new descriptions of 
markets for ‘bioelectronics’, ‘gene and cell editing’ and ‘big data’ which then had to be taken into 
account, precipitating further market conceptualisation work and broader discussions at Summit 
events on ‘health futures’.  
New conceptualisations of markets resulted in specific searches and connections for others to 
become part of the network, allowed some technologies to be suspended in states of stabilised 
uncertainty (precipitating ‘protected’ R&D funding and limited market activity – as in the case of 
bioelectronics) and others to be moved forward. For example, by the end of our 18-month study, the 
Gene and Cell Therapy Catapult5 were awarded significant space on the SBC site, and was becoming 
an increasingly influential actor within the strategic net.  
It is worth noting that conceptualising actor’s roles, markets and goods did not occur independently 
or sequentially as others might suggest (see for example, Carrillat, 2004; Jaworski et al., 2000). 
Rather, the entanglement of conceptualisation practices allowed actors in the strategic net to zoom 
in to the development of a various molecules and their potential market, before zooming out, to 
explore how a healthcare system might accommodate consumers with co-morbidities and complex 
medical and social care needs, as scientific discoveries advanced.  
5.0 DISCUSSION 
Our findings contribute to the strategic net literature by explicating strategic nets as actor-networks. 
This builds on a strong tradition of research on strategic networks of innovation (cf. Aarikka-Stenroos 
et al., 2014), by providing an in-depth empirical analysis of the powerful associations, deliberately 
and purposely generated by the co-ordinated and recursive practices of a strategic net. It 
foregrounds how actors in the network assemble and generate scientific, epistemic and technical 
objects in order to progress the marketization of scientific discoveries. The practices developed and 
performed by the strategic net, through their engagement in a process of marketization, generate 
                                                          
5
 The Cell and Gene Therapy Catapult is a centre of excellence in innovation, with the core purpose of building a world-
leading cell and gene therapy sector in the UK as a key part of a global industry. Supported by Innovate UK, their mission is 
to drive the growth of the industry by helping cell and gene therapy organisations across the world translate early stage 
research into commercially viable and investable therapies.  
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new and multiple market devices that become part of market architectures, so transforming how 
markets are performed (Çalışkan & Callon, 2010). This has two important theoretical implications. 
First, it suggests that conceptualisation practices generate conceptualisations of actors, markets and 
goods (and associations between them) that transform how markets are performed.   
Conceptualisations are re-presented and circulated, and act a market devices.  New market devices 
can re-configure how market actors act with regard to conventions and rules of the market (even 
when those rules are ‘new’),  the methods and instruments of valuation and scientific, technical and 
market knowledge (Çalışkan & Callon, 2010; Muniesa et al., 2007). We observed how the strategic 
net generates and circulates new market devices that are then picked up and used by multiple 
market actors to make judgements about how they should act in that market (cf. Callon, 2007; 
MacKenzie, 2006). This moves us some way towards understanding how conceptualisation practices 
influence particular markets and the broader system of provision, by showing that the market 
devices they produce re-configure markets, changing how they are performed through new 
conventions of calculating and valuing, and re-presentation of new forms of scientific and market 
knowledge. For example, we saw how, by circulating and problematizing extant understandings of 
the ‘commercialisation of science’, the strategic net set out to generate questions and gather 
together new understandings of why the market wasn’t working for scientific discoveries. These 
conceptualisations led to the introduction of new practices of connecting and reviewing the 
scientific-business developments of tenants with a broader group of market actors. Through such 
encounters new, often shared understandings of markets were generated (i.e. big pharma selling 
clinical trial services to scientists).  
These observations offer useful complementarities to Möller’s (2010) theorising of the importance of 
sense-making and agenda-setting capabilities in strategic nets. We demonstrate how such capabilities 
are performed in practice through the assembling of new scientific and market knowledge, which is 
re-presented at conferences, workshops, and in expert panels, as they are questioned and 
collectively negotiated. Sometimes referred to as overflowing and reframing (Callon, 1998b), this 
process creates new ways of understanding the science-market-health landscape and enables new 
forms of knowing to come to the fore. Overflows are a characteristic of the marketization process. 
Importantly here, it is the conceptualisation practices established by the strategic net that create 
overflows, inviting contestation and generation of new conceptualisations (cf. Cochoy & Dubuisson-
Quellier, 2013).  
These findings deepen extant understandings of the marketization work that strategic nets do by 
explicating a specific framing brought to it – that of ‘pacifying goods’ (Çalışkan & Callon, 2010: 5). The 
pacification of goods is described by Çalışkan and Callon as the work done to put goods into a state 
where they can be transferred as property. As we saw with the need for tentants to have ‘gold plated 
data’ (T#6), connecting specific scientific discoveries to considerations of the broader systems of 
provision foregrounds the reconceptualising of what needs to be ‘pacified’ and made stable in the 
market system and generates new insights for managers working out how to act and intervene. It is 
difficult to imagine how T#6’s ‘breakthrough’ with ‘big pharma’ to provide clinical trial services to 
scientist-entrepreneurs might have been achieved without the coordinated efforts of the strategic 
net. Conceptualisation practices are thus understood to be generative of the infrastructures 
necessary for the marketization of scientific discoveries.  
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Second, our findings have implications for how we understand the practices of the strategic net as 
constitutive of markets. By conceptualising strategic nets as actor-networks, we can explain how the 
routinized, recursive practices they perform (e.g. identifying, enrolling, mobilising actors etc.), 
reproduce the social bonds that organise and order markets and their institutions (Latour, 2005). The 
conceptualising practices we describe here reproduce a new the rules, conventions and instruments 
that shape how the market calculates what is of value to whom, and how such goods might 
practically be developed, produced and exchanged (cf. Araujo & Pels, 2015). While this ontology 
assumes the marketization process as never complete, recognizing markets as always in-the-making 
(Araujo, 2007), it also tells us something of the role of the strategic net in this process of becoming. 
In both equipping market actors to calculate in new ways, and in providing the mechanisms by which 
such market devices are continuously re-made (in the interest of innovative scientific discoveries), 
the strategic net’s practices are constitutive of ‘the market’.   
The way the term ‘the market’ is represented, materialised and discursively assembled (Muniesa et 
al., 2007: 2) through the strategic net’s conceptualisation practices, is also informative in helping us 
understand constitutive nature of conceptualisation practices. Our respondents talked about 
scientific discoveries: both within markets (e.g. ‘health robotics’ ‘gene therapies’, ‘e-health’), and 
across markets (e.g. ‘healthcare’, ‘health futures’), often imagining quite radical changes to 
healthcare provision by anticipating the collision or convergence between markets and technologies.  
This ‘comfortable shift’ (SBC#4) between various scopes and scales in the representation of markets -  
from narrowly defined ‘treatments for inflammatory diseases’ to much broader conceptualisations 
of ‘health futures’, emerged specifically from the conceptualising practices of the strategic net. 
Indeed, one could argue that this is exactly what the conceptualisation practices were designed to 
produce.  But, by continuously zooming-in and zooming-out of markets, and by constantly varying 
the scope and scale of the focus, the strategic net generated market devices that ordered and 
organised at multiple scales.  Thus the conceptualising practices of the strategic net become 
constitutive of ‘health futures’.  Seeing strategic nets as constitutive of markets builds on extant 
understandings of field-shaping (cf. Möller, 2006; Möller, 2010)  where markets-as-networks are 
understood to be transformed through the actions (and interactions) of the various network 
members (Möller & Svahn, 2009). Additionally, our data suggest that strategic nets are central 
institutions in the constitution of broader systems such as healthcare provision.    
These findings also contribute to strategic studies on the importance of visualising powerful 
associations between organisations. For example, in their study of six entrepreneurial rivals in the 
gaming industry, Ozcan and Eisenhardt (2009) found that firms with high-performing portfolios of 
alliances, visualise their portfolios in the context of an entire business network rather than as a series 
of single ties. Ozcan and Eisenhardt (2009) argue that this generates a holistic understanding of 
possible interdependencies among firms, the locations of unconnected firms and the presence of 
industry uncertainties. Similarly, by continuously mapping, negotiating and remapping broader 
systems of provision, our strategic net were able to broaden the range of strategic alternatives and 
enrich the strategic possibilities for scientific discoveries. This raises interesting question about the 
plasticity of strategic nets.  
While we accept Möller, Rajala and Svahn’s (2005:1275) definition of strategic nets as, ‘intentionally 
formed networks that contain a finite set of parties, at least three’, we observed their plastic nature 
as different members of the strategic net performed conceptualising practices. For example, as 
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tenants’ discoveries unfolded, different actors within the strategic net were mobilised or 
backgrounded. Further, while the core members of the net remained quite stable, other actors were 
temporarily enrolled into its activities before moving on, while yet other market actors remained 
more distant, connected only through engagements at Summits, roundtables and other networking 
events. This is a somewhat different understanding of strategic nets. Rather than claiming a stable 
well-defined value system or recognising an emergent value system such as those associated with 
radical innovation and change (see for example, Harrison et al., 2010; Möller et al., 2005), it suggests 
a dynamic conceptualisation of a strategic net,  reproduced through its everyday practices. 
6.0 CONCLUSION AND MANAGERIAL IMPLICATIONS  
6.1 Theoretical Implications 
Our study set out not only to identify the types of practices performed by a strategic net to generate 
new and disruptive market devices, but also to explain how conceptualisation practices influence 
particular markets and the broader system of provision.   In so doing we make three key 
contributions to the strategic nets literature.  
First, our findings contribute to the strategic net literature by presenting some of the first empirical 
evidence of the practices performed by strategic nets (Möller, 2010). We identified three specific 
forms of conceptualisation work performed as a central part of the marketization process: 1) the 
conceptualisation of actors’ roles, 2) the conceptualisations of markets, and, 3) the conceptualisation 
of goods. These findings show the strategic net as a well-positioned and well-equipped institutional 
form for engaging in marketization, and more specifically conceptualisation work. By drawing on 
extant research into the sociology of marketing work (Cochoy & Dubuisson-Quellier, 2013), we show 
how the conceptualisation practices can be strategic, and central to the co-ordinated collective 
actions that create and develop markets. Additionally the varied and distributed forms of knowledge 
‘held together’ (SBC#4) by the strategic net, continuously enable it to re-conceptualise goods and 
markets at different scopes and scales.   
Second, our findings position the conceptualisation practices of strategic nets as constitutive of 
markets. This goes further than extant understandings of strategic networks that are said to 
influence markets (see, Aarikka-Stenroos et al., 2014), and instead claims that the routinized, 
recursive nature of conceptualisation practices actually becomes part of the market architectures 
that reproduce social bonds (Latour, 2005) and bridge different communities of practice (Möller & 
Svahn, 2006). In particular it is through these specific forms of conceptualisation work that strategic 
nets act to continuously generate new market devices that can calculate, both within and across 
these communities of practice, the unfolding value of scientific discoveries.    
There is an important point here, relating to how we understand the dynamic and unfolding nature 
of not just scientific discoveries as they are launched into the worlds of markets, but also of the 
institutional architectures and more specifically, the strategic nets that come to accommodate them.  
While Möller & Rajala (2007) explicate the basic types of strategic nets they are relatively silent 
about the network dynamics.  However, they suggest that there may be variation in stability of the 
different forms. While Möller and Svahn (2003: 220) proposed a value system continuum, they 
concede, “In reality, we will never find completely determined or undetermined systems. … strategic 
nets 'stretch' across at least two ideal types. Various nets are generally interrelated through actors 
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having roles in several. This kind of multiple involvements allows innovative companies, through 
their accumulated knowledge of other relevant actors and their capabilities and liaisons, to create 
temporal strategic nets for specific development purposes.” In other words, strategic nets are 
constant evolution. We concur with this view, finding that the plastic nature of strategic nets, their 
ability to morph and alter to accommodate new and emergent market objects, to be central to their 
ability to recursively reconceptualise markets for scientific discoveries.  
Finally, we show how, through its conceptualisation work, the strategic net is able to explore 
opportunities far beyond commercialisation. By generating conceptualisations of broader systems of 
provision they are able to pursue a much broader agenda of the marketization of science (cf. Möller, 
2010). While commercialisation focuses on the transformation of a specific form of scientific 
knowledge into something that can be made tradeable and valuable to others (Perkmann et al., 
2013; Zucker & Darby, 1996), marketization is much broader and includes mapping out and re-
imagining markets, the roles of multiple and varied actors and the practices needed to make the 
broader market system work (cf. Callon, 2016). The need to co-ordinate this purposive, socio-
cognitive work ideally positions the strategic net and it’s collective of co-ordinated actors, for 
gathering together, conceptualising and circulating understandings of how a transformed market 
might be performed (cf. Möller & Rajala, 2007; Möller et al., 2005), and to build powerful 
associations that put such conceptualisations into practice. 
6.2 Managerial Implications 
This research offers managers and scientists a greater depth and clarity of understanding of the 
marketization process in early-stage biotechnology innovation settings.  The three-part 
conceptualizations of collective market action and the work done to create tradeable goods not only 
highlight the ways in which biotech incubators can become important agents in the advancement of 
biomedical science, but also offer the necessarily fine-grained knowledge platform for improved 
management, governance and appraisal of these sites of incubation.  For managers of established 
and new incubators these concepts provide a way of analysing, discussing, planning and reporting on 
their incubation-supporting activities. For governing boards, investors and governments this gives a 
clearer framework for the understanding and appraisal of the work done in such settings, not only as 
it is carried out by the directly employed managers of the incubator, but also the work done by the 
strategic net. For scientists operating within incubators, or considering where to locate themselves 
and their embryonic innovations, this offers a way of understanding the practices and processes that 
they are about to engage in as they consider their move towards the marketization of their ideas, 
and at the same time a framework for assessing the most suitable incubator setting in which to 
locate themselves.  
For managers and scientists, these findings are also important in that they do not merely provide 
conceptual labels, but they emphasise the dynamic nature of markets, the interdependency of firms, 
and therefore the need to continually explore, re-map and re-present their emergent 
understandings of markets, market action, and the nature of their goods.  By drawing out the role of 
strategic nets in gathering together market knowledge, and the types of strategizing and marketing 
practices that act to reproduce and reshape markets, we offer both existing and aspirant managers 
an important lens through which they can better understand and influence strategic market action. 
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Our findings imply that managers wishing to transform markets can intervene effectively through 
collective, co-ordinated action, conceptualised through the activities of a strategic net. Findings 
outline the practices through which effective strategic nets are formed. Managers developing 
connections and activities that both support and shape policy put themselves in a strong position to 
identify and co-create effective, market-transforming strategic nets.  Additionally, findings identify 
and describe the types of marketing and strategizing practices that managers should engage in if 
their intent is to transform markets. By being part of a strategic net that gathers together key and 
emergent market knowledge and expertise from diverse market actors (often found outside or on 
the edges of a field), managers are well-positioned to effect changes in market architectures. But 
managers also need to consider the dynamics of markets in conjunction with their strategic net’s 
activities, enabling one to inform and unfold the other. Exploring, re-mapping and re-presenting of 
emergent interdependency - not just between firms and markets but between interconnected 
networks of firms performing, reproducing and reshaping markets - offers a fundamentally different 
lens for managers attempting to understand and influence strategic market action.  
Understanding the value of strategic nets and their capacity to transform markets through the 
conceptualising practices they perform, also has important policy implications. The Stevenage 
BioScience Catalyst, like many science and technology incubators and accelerators world-wide, 
benefited from significant government funding. Our findings suggest that conceptualisation practices 
can play an important role in reconstituting markets for innovation. This has important implications 
for policy makers as it suggests that the way we value strategic net practices, needs to take into 
account their constitute contribution to market innovation and transformation. This might shed a 
very different light on value of such initiatives than current evaluations allow. While such is beyond 
the scope of this study, it suggests an important area for further research. 
6.3 Limitations and Future Research 
Our findings have limitations and implications for further study. Life Science is generally a slow 
business. The findings presented here focus on the conceptualisation work that a strategic net 
performs largely because, despite the 18-month period over which our data collection extended, no 
new products from the biotech start-ups were launched onto the market. This is not surprising, given 
the historical drug development patterns of this sector, or that we were studying the activities of an 
‘incubator’ (rather than an accelerator or science park that supports more advanced science). 
However, this observation foregrounds the need for further longitudinal studies in biotechnology to 
enable researchers to generate a more comprehensive map of marketization, from conceptualisation 
to market transformation to the connections between multiple markets as they unfold the broader 
systems of health provision.   
We also need studies that examine the relationships of strategic nets and marketization beyond the 
biotechnology sector. By studying other industries and market settings we will be able to develop a 
much fuller picture of the marketization process. Such studies are not feasible for the lone 
researcher, but present important opportunities for multi- and inter-disciplinary research teams 
engaged in extended, longitudinal research programmes. Such studies are likely to generate 
insightful and valuable understandings of the marketization process and the activities of managers 
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